Mesquite, TX, United States of America

Leslie D Cope

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2000-2009

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Leslie D Cope: Innovator in Molecular Biology

Introduction

Leslie D Cope is a prominent inventor based in Mesquite, TX (US). She has made significant contributions to the field of molecular biology, particularly through her innovative research and patents. With a total of 7 patents, her work has had a substantial impact on the scientific community.

Latest Patents

One of her latest patents involves the discovery of UspA2 nucleic acid of Moraxella catarrhalis. This invention discloses the existence of two novel proteins, UspA1 and UspA2, along with their respective genes, uspA1 and uspA2. Each protein contains a conserved region and an epitope recognized by the MAb 17C7. These proteins may aggregate to form a very high molecular weight form of the UspA antigen, exceeding 200 kDa. The patent also includes compositions and methods for both diagnostic and therapeutic applications related to this discovery.

Career Highlights

Leslie has worked with the University of Texas System, where she has contributed to various research projects and initiatives. Her work has been instrumental in advancing the understanding of molecular biology and its applications in medicine.

Collaborations

Leslie has collaborated with notable coworkers, including Eric J Hansen and Christoph Aebi. These partnerships have further enriched her research and innovation efforts.

Conclusion

Leslie D Cope is a remarkable inventor whose contributions to molecular biology continue to influence the field. Her innovative patents and collaborative efforts highlight her dedication to advancing scientific knowledge and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…